These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26004686)

  • 1. Metabolic syndrome in drug-naïve and drug-free patients with schizophrenia and in their siblings.
    Enez Darcin A; Yalcin Cavus S; Dilbaz N; Kaya H; Dogan E
    Schizophr Res; 2015 Aug; 166(1-3):201-6. PubMed ID: 26004686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low prevalence of obesity and metabolic syndrome in never-treated chronic schizophrenia.
    Padmavati R; McCreadie RG; Tirupati S
    Schizophr Res; 2010 Aug; 121(1-3):199-202. PubMed ID: 20538429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The METEOR study: frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs.
    Falissard B; Mauri M; Shaw K; Wetterling T; Doble A; Giudicelli A; De Hert M
    Int Clin Psychopharmacol; 2011 Nov; 26(6):291-302. PubMed ID: 21876442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome in schizophrenia: a comparative study of antipsychotic-free/naïve and antipsychotic-treated patients from India.
    Pallava A; Chadda RK; Sood M; Lakshmy R
    Nord J Psychiatry; 2012 Jun; 66(3):215-21. PubMed ID: 22017264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: a cohort study.
    Bai YM; Chen TT; Yang WS; Chi YC; Lin CC; Liou YJ; Wang YC; Su TP; Chou P; Chen JY
    Schizophr Res; 2009 Jun; 111(1-3):1-8. PubMed ID: 19409756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication.
    De Hert MA; van Winkel R; Van Eyck D; Hanssens L; Wampers M; Scheen A; Peuskens J
    Schizophr Res; 2006 Mar; 83(1):87-93. PubMed ID: 16481149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical antipsychotic drugs, schizophrenia, and metabolic syndrome in non-Euro-American societies.
    Bou Khalil R
    Clin Neuropharmacol; 2012; 35(3):141-7. PubMed ID: 22592510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered metabolic parameters in association with antipsychotic medication use in diabetes: A population based case-control study.
    Wake DJ; Broughton P; Perera SM; MacIntyre DJ; Leese GP
    Psychoneuroendocrinology; 2016 Apr; 66():214-20. PubMed ID: 26849203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of the metabolic syndrome in schizophrenic patients receiving second-generation antipsychotic agents--a cross-sectional study.
    Kagal UA; Torgal SS; Patil NM; Malleshappa A
    J Pharm Pract; 2012 Jun; 25(3):368-73. PubMed ID: 22551560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder.
    van Winkel R; De Hert M; Van Eyck D; Hanssens L; Wampers M; Scheen A; Peuskens J
    Bipolar Disord; 2008 Mar; 10(2):342-8. PubMed ID: 18271914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linkage of cognitive impairments with metabolic disorders in schizophrenia.
    Nasrallah HA
    Am J Psychiatry; 2010 Oct; 167(10):1155-7. PubMed ID: 20889659
    [No Abstract]   [Full Text] [Related]  

  • 13. A two fold risk of metabolic syndrome in a sample of patients with schizophrenia: do consanguinity and family history increase risk?
    Bener A; Al-Hamaq AO; Dafeeah EE
    Diabetes Metab Syndr; 2014; 8(1):24-9. PubMed ID: 24661754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic risk factors in drug-naive patients with first-episode psychosis.
    Verma SK; Subramaniam M; Liew A; Poon LY
    J Clin Psychiatry; 2009 Jul; 70(7):997-1000. PubMed ID: 19497246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and antipsychotic monotherapy treatment among schizophrenia patients in Malaysia.
    Said MA; Hatim A; Habil MH; Zafidah W; Haslina MY; Badiah Y; Ramli MA; Ananjit S; Sapini Y; Shah M; Mahmud B; Bulgiba A; Hairi NN
    Prev Med; 2013; 57 Suppl():S50-3. PubMed ID: 23337566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and predictors of metabolic syndrome in patients with schizophrenia and healthy controls: A study in rural South Indian population.
    Rawat VS; Ganesh S; Bijjal S; Shanivaram Reddy K; Agarwal V; Devi R; Kumar CN; Christopher R; Thirthalli J
    Schizophr Res; 2018 Feb; 192():102-107. PubMed ID: 28454923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome in first episode schizophrenia - a randomized double-blind controlled, short-term prospective study.
    Saddichha S; Manjunatha N; Ameen S; Akhtar S
    Schizophr Res; 2008 Apr; 101(1-3):266-72. PubMed ID: 18262771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome in antipsychotic naïve patients diagnosed with schizophrenia.
    Grover S; Nebhinani N; Chakrabarti S; Parakh P; Ghormode D
    Early Interv Psychiatry; 2012 Aug; 6(3):326-31. PubMed ID: 22176701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comparison of glycometabolism parameters and lipid profiles between drug-naïve, first-episode schizophrenia patients and healthy controls.
    Wu X; Huang Z; Wu R; Zhong Z; Wei Q; Wang H; Diao F; Wang J; Zheng L; Zhao J; Zhang J
    Schizophr Res; 2013 Oct; 150(1):157-62. PubMed ID: 23998954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome.
    Meyer JM; Nasrallah HA; McEvoy JP; Goff DC; Davis SM; Chakos M; Patel JK; Keefe RS; Stroup TS; Lieberman JA
    Schizophr Res; 2005 Dec; 80(1):9-18. PubMed ID: 16125372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.